Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio.

Shinde A, Horne ZD, Li R, Glaser S, Massarelli E, Koczywas M, Erhunmwunsee L, Reckamp KL, Weksler B, Salgia R, Beriwal S, Amini A.

Lung Cancer. 2019 Jul;133:136-143. doi: 10.1016/j.lungcan.2019.05.020. Epub 2019 May 19.

PMID:
31200820
2.

National patterns of care for early-stage penile cancers in the United States: How is radiation and brachytherapy utilized?

Mulherkar R, Hasan S, Wegner RE, Verma V, Glaser SM, Kalash R, Beriwal S, Horne ZD.

Brachytherapy. 2019 May 21. pii: S1538-4721(19)30084-4. doi: 10.1016/j.brachy.2019.04.007. [Epub ahead of print]

PMID:
31126857
3.

Impact of histological grade on oncologic outcomes in clinical stage I patients with endometrial carcinoma patients after definitive primary radiation therapy.

Suarez Mora A, Horne Z, Taylor S, Olawaiye AB, Beriwal S, Boisen M, Berger J, Sukumvanich P.

Int J Gynecol Cancer. 2019 May 10. pii: ijgc-2018-000124. doi: 10.1136/ijgc-2018-000124. [Epub ahead of print]

PMID:
31079061
4.

Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications.

Abel S, Hasan S, Horne ZD, Colonias A, Wegner RE.

Lung Cancer Manag. 2019 Feb 27;8(1):LMT09. doi: 10.2217/lmt-2018-0013. eCollection 2019 Feb. Review.

5.

The role of adjuvant therapy for atypical bronchopulmonary carcinoids.

Wegner RE, Abel S, Hasan S, Horne ZD, Colonias A, Weksler B, Verma V.

Lung Cancer. 2019 May;131:90-94. doi: 10.1016/j.lungcan.2019.03.022. Epub 2019 Mar 25.

PMID:
31027704
6.

National trends in radiation dose escalation for glioblastoma.

Wegner RE, Abel S, Horne ZD, Hasan S, Verma V, Ranjan T, Williamson RW, Karlovits SM.

Radiat Oncol J. 2019 Mar;37(1):13-21. doi: 10.3857/roj.2019.00017. Epub 2019 Mar 31.

7.

Explanation as a Cognitive Process.

Horne Z, Muradoglu M, Cimpian A.

Trends Cogn Sci. 2019 Mar;23(3):187-199. doi: 10.1016/j.tics.2018.12.004. Epub 2019 Jan 15. Review.

PMID:
30658885
8.

Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysis.

Wegner RE, Abel S, White RJ, Horne ZD, Hasan S, Kirichenko AV.

Radiat Oncol J. 2018 Dec;36(4):276-284. doi: 10.3857/roj.2018.00465. Epub 2018 Dec 31.

9.

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

Horne ZD, Karukonda P, Kalash R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Bochmeier MM, Berger JL, Taylor SE, Sukumvanich P, Beriwal S.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):157-164. doi: 10.1016/j.ijrobp.2018.12.042. Epub 2018 Dec 31.

PMID:
30605752
10.

Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?

Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Farrugia DJ, Diego E, Ahrendt GM, Beriwal S.

Adv Radiat Oncol. 2018 Apr 24;3(3):258-264. doi: 10.1016/j.adro.2018.03.004. eCollection 2018 Jul-Sep.

11.

Definitive local therapy is associated with improved overall survival in metastatic cervical cancer.

Venigalla S, Guttmann DM, Horne ZD, Carmona R, Shabason JE, Beriwal S.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):e377-e385. doi: 10.1016/j.prro.2018.05.010. Epub 2018 May 26.

PMID:
30174248
12.

The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant Radiation.

Dohopolski MJ, Horne ZD, Pradhan D, Bhargava R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Berger JL, Sukumvanich P, Beriwal S.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):152-160. doi: 10.1016/j.ijrobp.2018.08.014. Epub 2018 Aug 16.

PMID:
30121234
13.

Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy.

Horne ZD, Dohopolski MJ, Pradhan D, Bhargava R, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks MB, Bockmeier MM, Berger JL, Taylor SE, Sukumvanich P, Beriwal S.

Gynecol Oncol. 2018 Oct;151(1):96-101. doi: 10.1016/j.ygyno.2018.08.002. Epub 2018 Aug 3.

PMID:
30082072
14.

Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field.

Horne ZD, Dohopolski MJ, Clump DA, Burton SA, Heron DE.

Pract Radiat Oncol. 2018 May - Jun;8(3):e117-e123. doi: 10.1016/j.prro.2017.11.011. Epub 2017 Dec 8.

PMID:
29724402
15.

Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease.

Dohopolski MJ, Horne Z, Clump D, Burton SA, Heron DE.

Cureus. 2018 Feb 7;10(2):e2167. doi: 10.7759/cureus.2167.

16.

Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.

Kalash R, Glaser SM, Rangaswamy B, Horne ZD, Kim H, Houser C, Beriwal S.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1008-1013. doi: 10.1016/j.ijrobp.2018.01.092. Epub 2018 Feb 6.

PMID:
29559287
17.

Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?

Dohopolski MJ, Horne ZD, Gebhardt BJ, Glaser SM, Edwards RP, Kelley JL, Comerci JT, Olawaiye AB, Courtney-Brooks M, Berger JL, Sukumvanich P, Beriwal S.

Brachytherapy. 2018 May - Jun;17(3):564-570. doi: 10.1016/j.brachy.2018.01.004. Epub 2018 Feb 14.

PMID:
29426745
18.

Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.

Horne ZD, Richman AH, Dohopolski MJ, Clump DA, Burton SA, Heron DE.

Lung Cancer. 2018 Jan;115:1-4. doi: 10.1016/j.lungcan.2017.10.014. Epub 2017 Nov 10.

PMID:
29290248
19.

Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network.

Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Ahrendt GM, Diego E, Heron DE, Beriwal S.

Pract Radiat Oncol. 2018 Jan - Feb;8(1):4-12. doi: 10.1016/j.prro.2017.07.012. Epub 2017 Jul 20.

PMID:
28939351
20.

Standardization of radiation therapy dose for locally advanced non-small cell lung cancer through changes to a lung cancer clinical pathway in a large, integrated comprehensive cancer center network.

Karukonda P, Gebhardt BJ, Horne ZD, Heron DE, Beriwal S.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e551-e557. doi: 10.1016/j.prro.2017.07.003. Epub 2017 Jul 8.

PMID:
28867544
21.

Moral Severity is Represented as a Domain-General Magnitude.

Powell D, Horne Z.

Exp Psychol. 2017 Mar;64(2):142-147. doi: 10.1027/1618-3169/a000354.

PMID:
28497722
22.

Registered Replication Report: Rand, Greene, and Nowak (2012).

Bouwmeester S, Verkoeijen PPJL, Aczel B, Barbosa F, Bègue L, Brañas-Garza P, Chmura TGH, Cornelissen G, Døssing FS, Espín AM, Evans AM, Ferreira-Santos F, Fiedler S, Flegr J, Ghaffari M, Glöckner A, Goeschl T, Guo L, Hauser OP, Hernan-Gonzalez R, Herrero A, Horne Z, Houdek P, Johannesson M, Koppel L, Kujal P, Laine T, Lohse J, Martins EC, Mauro C, Mischkowski D, Mukherjee S, Myrseth KOR, Navarro-Martínez D, Neal TMS, Novakova J, Pagà R, Paiva TO, Palfi B, Piovesan M, Rahal RM, Salomon E, Srinivasan N, Srivastava A, Szaszi B, Szollosi A, Thor KØ, Tinghög G, Trueblood JS, Van Bavel JJ, van 't Veer AE, Västfjäll D, Warner M, Wengström E, Wills J, Wollbrant CE.

Perspect Psychol Sci. 2017 May;12(3):527-542. doi: 10.1177/1745691617693624. Epub 2017 Mar 1.

23.

How Large Is the Role of Emotion in Judgments of Moral Dilemmas?

Horne Z, Powell D.

PLoS One. 2016 Jul 6;11(7):e0154780. doi: 10.1371/journal.pone.0154780. eCollection 2016.

24.

Marginally Significant Effects as Evidence for Hypotheses: Changing Attitudes Over Four Decades.

Pritschet L, Powell D, Horne Z.

Psychol Sci. 2016 Jul;27(7):1036-42. doi: 10.1177/0956797616645672. Epub 2016 May 16.

PMID:
27207874
25.

Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.

Horne ZD, Glaser SM, Vargo JA, Ferris RL, Balasubramani GK, Clump DA, Heron DE, Beriwal S.

Cancer. 2016 Jul 1;122(13):2021-30. doi: 10.1002/cncr.30021. Epub 2016 Apr 25.

26.

The Frequency of "Brilliant" and "Genius" in Teaching Evaluations Predicts the Representation of Women and African Americans across Fields.

Storage D, Horne Z, Cimpian A, Leslie SJ.

PLoS One. 2016 Mar 3;11(3):e0150194. doi: 10.1371/journal.pone.0150194. eCollection 2016.

27.

Reply to Betsch et al.: Highlighting risks of diseases shifts vaccine attitudes.

Horne Z, Powell D, Hummel JE, Holyoak KJ.

Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6727. doi: 10.1073/pnas.1517936112. Epub 2015 Nov 23. No abstract available.

28.

Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery.

Quan K, Xu KM, Lalonde R, Horne ZD, Bernard ME, McCoy C, Clump DA, Burton SA, Heron DE.

Front Oncol. 2015 Oct 6;5:213. doi: 10.3389/fonc.2015.00213. eCollection 2015.

29.

Psychological Impact of Nuclear Disasters in Children and Adolescents.

Latif F, Yeatermeyer J, Horne ZD, Beriwal S.

Child Adolesc Psychiatr Clin N Am. 2015 Oct;24(4):811-22. doi: 10.1016/j.chc.2015.06.009. Epub 2015 Jul 3. Review.

PMID:
26346391
30.

Countering antivaccination attitudes.

Horne Z, Powell D, Hummel JE, Holyoak KJ.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10321-4. doi: 10.1073/pnas.1504019112. Epub 2015 Aug 3.

31.

A Bayesian framework for knowledge attribution: evidence from semantic integration.

Powell D, Horne Z, Pinillos NÁ, Holyoak KJ.

Cognition. 2015 Jun;139:92-104. doi: 10.1016/j.cognition.2015.03.002. Epub 2015 Mar 23.

PMID:
25813346
32.

A Single Counterexample Leads to Moral Belief Revision.

Horne Z, Powell D, Hummel J.

Cogn Sci. 2015 Nov;39(8):1950-64. doi: 10.1111/cogs.12223. Epub 2015 Mar 23.

33.

Hypofractionated stereotactic body radiation therapy for elderly patients with stage IIB-IV nonsmall cell lung cancer who are ineligible for or refuse other treatment modalities.

Karam SD, Horne ZD, Hong RL, McRae D, Duhamel D, Nasr NM.

Lung Cancer (Auckl). 2014 Oct 3;5:59-66. doi: 10.2147/LCTT.S66395. eCollection 2014.

34.

Pretreatment SUVmax as a Marker for Progression-Free Survival in Stage I NSCLC Treated With SBRT.

Horne ZD, Clump DA, Shah S, Vargo JA, Burton SA, Christie NA, Schuchert MJ, Landreneau RJ, Luketich JD, Heron DE.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S3-4. doi: 10.1016/j.prro.2013.01.014. Epub 2013 Mar 25. No abstract available.

PMID:
24674539
35.

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.

Horne ZD, Clump DA, Vargo JA, Shah S, Beriwal S, Burton SA, Quinn AE, Schuchert MJ, Landreneau RJ, Christie NA, Luketich JD, Heron DE.

Radiat Oncol. 2014 Jan 30;9:41. doi: 10.1186/1748-717X-9-41.

36.

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

Pogue-Geile KL, Kim C, Jeong JH, Tanaka N, Bandos H, Gavin PG, Fumagalli D, Goldstein LC, Sneige N, Burandt E, Taniyama Y, Bohn OL, Lee A, Kim SI, Reilly ML, Remillard MY, Blackmon NL, Kim SR, Horne ZD, Rastogi P, Fehrenbacher L, Romond EH, Swain SM, Mamounas EP, Wickerham DL, Geyer CE Jr, Costantino JP, Wolmark N, Paik S.

J Natl Cancer Inst. 2013 Dec 4;105(23):1782-8. doi: 10.1093/jnci/djt321. Epub 2013 Nov 21.

37.

Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer.

Karam SD, Horne ZD, Hong RL, Baig N, Gagnon GJ, McRae D, Duhamel D, Nasr NM.

Lung Cancer (Auckl). 2013 Aug 6;4:35-42. doi: 10.2147/LCTT.S48121. eCollection 2013.

38.

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.

Karam SD, Horne ZD, Hong RL, McRae D, Duhamel D, Nasr NM.

Radiat Oncol. 2013 Jul 10;8:179. doi: 10.1186/1748-717X-8-179.

39.

The use of stereotactic body radiation therapy for local control of glomangiomatosis: a case report.

Horne ZD, Karam SD, Rashid A, Snider JW, Lax A, Ozdemirli M, Harter KW.

Front Oncol. 2013 Mar 5;3:26. doi: 10.3389/fonc.2013.00026. eCollection 2013.

40.

Extended Chamberlain minithoracotomy: a safe and versatile approach for difficult lung resections.

Schuchert MJ, Souza AP, Abbas G, Pennathur A, Nason KS, Jack R, Horne ZD, Landreneau JR, Santana M, Wilson DO, Luketich JD, Landreneau RJ.

Ann Thorac Surg. 2012 May;93(5):1641-5; discussion 1646. doi: 10.1016/j.athoracsur.2011.11.010. Epub 2012 Mar 28.

PMID:
22464035
41.

Influence of age and IB status after resection of node-negative non-small cell lung cancer.

Schuchert MJ, Awais O, Abbas G, Horne ZD, Nason KS, Pennathur A, Souza AP, Siegfried JM, Wilson DO, Luketich JD, Landreneau RJ.

Ann Thorac Surg. 2012 Mar;93(3):929-35; discussion 935-6. doi: 10.1016/j.athoracsur.2011.09.047.

PMID:
22364984
42.

Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.

Horne ZD, Jack R, Gray ZT, Siegfried JM, Wilson DO, Yousem SA, Nason KS, Landreneau RJ, Luketich JD, Schuchert MJ.

J Surg Res. 2011 Nov;171(1):1-5. doi: 10.1016/j.jss.2011.03.068. Epub 2011 Apr 22.

PMID:
21571304
43.

Endoluminal management of bronchogenic carcinoma in 2010: diagnosis, staging, and therapy.

Horne ZD, Landreneau RJ, Luketich JD, Schuchert MJ.

Minerva Chir. 2010 Dec;65(6):635-54. Review.

PMID:
21224798
44.

Immunohistochemical evidence for an association of ribosomes with microfilaments in 3T3 fibroblasts.

Hesketh JE, Horne Z, Campbell GP.

Cell Biol Int Rep. 1991 Feb;15(2):141-50.

PMID:
2029732

Supplemental Content

Support Center